<html>
<head>PUBMED IDs for LZTS2</head>
<body bgcolor='#C5F0F2'><h1>LZTS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16012743/'>In silico characterization of LZTS3, a potential tumor suppressor.</a> July 14  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17000760/'>LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin.</a> September 27  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17982636/'>A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490357/'>LAPSER1/LZTS2: a pluripotent tumor suppressor linked to the inhibition of katanin-mediated microtubule severing.</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490349/'>Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction.</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490283/'>Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: are all etiologies identical?</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/23275340/'>Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.</a> April 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23275340/'>Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.</a> April 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23761130/'>Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.</a> November 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/28323888/'>LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.</a> March 23  2017<br></body></html>
